Pharmacologic and clinical assessment of kratom.

@article{White2018PharmacologicAC,
  title={Pharmacologic and clinical assessment of kratom.},
  author={C. White},
  journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  year={2018},
  volume={75 5},
  pages={
          261-267
        }
}
  • C. White
  • Published 2018
  • Medicine
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • PURPOSE This article reviews the pharmacology, clinical utility, adverse effects, and abuse potential of kratom. SUMMARY The leaves of Mitragyna speciosa contain the biologically active alkaloids of kratom. Kratom exerts opioid and α-2 receptor agonistic effects as well as antiinflammatory and parasympathetic-impeding effects. There are no published human pharmacologic, pharmacokinetic, or drug interaction studies on kratom or mitragynine, making it virtually impossible to fully understand… CONTINUE READING
    21 Citations
    Pharmacologic and clinical assessment of kratom: An update.
    • C. White
    • Medicine
    • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
    • 2019
    • 2
    A Case of Kratom-induced Seizures
    • 2
    • PDF
    The Potential for Kratom as an Antidepressant and Antipsychotic
    Neonatal Withdrawal Following in Utero Exposure to Kratom
    • 2
    • PDF

    References

    SHOWING 1-10 OF 36 REFERENCES
    Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.
    • 119
    • Highly Influential
    • PDF
    Abuse potential and adverse cognitive effects of mitragynine (kratom)
    • 53
    • Highly Influential
    From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction
    • 163
    • Highly Influential
    • PDF
    Experiences of Kratom Users: A Qualitative Analysis
    • 62
    • PDF
    A Case Report of Inpatient Detoxification after Kratom (Mitragyna speciosa) Dependence
    • 67
    Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users.
    • 116
    Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers - United States, 2010-2015.
    • 71
    • Highly Influential
    • PDF
    Social Functioning of Kratom (Mitragyna speciosa) Users in Malaysia
    • 42
    • PDF
    How MDMA's Pharmacology and Pharmacokinetics Drive Desired Effects and Harms
    • 30
    • Highly Influential